A Study of BEZ235 in Adult Japanese Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
In this study, BEZ235 will be administered to adult patients with advanced solid tumors whose
disease has progressed despite standard therapy or for whom no standard therapy exists. The
trial will confirmed the safety and tolerability and determine the MTD of BEZ235 in Japanese
patients.